Results 181 to 190 of about 1,588,451 (244)
In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma
By employing in vivo CRISPR functional screening, we identify ribosomal protein RPS19 as a pivotal mediator driving immune evasion in hepatocellular carcinoma, wherein tumor‑released RPS19 binds C5aR1 on tumor‑associated macrophages to initiate downstream immunosuppressive signaling; SP94‑peptide‑modified SNPSS nanoparticles deliver Cas9/sgRPS19 ...
Lei He +20 more
wiley +1 more source
PD-L1 in Merkel Cell Carcinoma: From Tumor Microenvironment to Pathological Interpretation. [PDF]
Pepe L +7 more
europepmc +1 more source
A carrier‐free peptide‐guided PSP@IR‐CF3 nanofiber system integrates PD‐L1 targeting and photothermal immunotherapy for enhanced cancer treatment. By revealing PTIT‐induced activation of the HSP70/AKT/mTOR pathway and incorporating mTOR inhibition, this strategy effectively overcomes therapeutic resistance and prevents tumor recurrence, providing a ...
Xinyu Zhang +11 more
wiley +1 more source
PD-L1 immunoreactivity and its association with tumor grade in canine mammary carcinomas. [PDF]
Duarte-Isaza GP +4 more
europepmc +1 more source
A biomimetic nanoplatform (RPm@CC‐LY) remodels fibrotic stroma via sustained TGF‐β inhibition, triggers oxidative stress and apoptosis through Cu+‐mediated Fenton chemistry and Ca2+ overload, and reprograms macrophages and dendritic cells to boost CD8+ T cell infiltration.
Jianmei Li +6 more
wiley +1 more source
Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment. [PDF]
Kciuk M, Kołat D, Wanke K, Kontek R.
europepmc +1 more source
Photoelectrocatalytic Diazidation of Olefins via Synergistic Dual Iron Species
We report a simple and general approach for 1,2‐diazidation of alkenes by a photoelectrochemical strategy using TMSN3 as an azide source. This transformation proceeds using earth‐abundant iron under mild reaction conditions. It displays broad functional group compatibility and accommodates diverse alkene types‐including unactivated, activated, electron‐
Zhi‐Peng Guan +6 more
wiley +1 more source
Targeting RPL4 improves the therapeutic efficacy of PD-L1 blockade in liver fibrosis. [PDF]
Zhang J +9 more
europepmc +1 more source
BRCA1 mutation‐responsive FBOA‐tFNA selectively recognizes mutant transcripts and coordinates reduction‐responsive intracellular delivery of olaparib and adavosertib, amplifying DNA damage and weakening G2/M checkpoint protection. These effects are accompanied by STING‐associated immune activation and stronger antitumor immunity, while sequential anti ...
Chenyi Wang +7 more
wiley +1 more source
PCAT6 Regulates IGF2BP1/PD-L1 to Promote Immune Escape in Breast Cancer. [PDF]
Sun D +5 more
europepmc +1 more source

